Furthermore, rottlerin inhibited PI3K (phosphoinositide 3-kinase)/Akt/mTOR (mammalian target of rapamycin) pathway, leading to autophagy and apoptosis in pancreatic cancer stem cells [33] and prostate cancer cells [34]. The gene discussed is AKT1; the disease is prostate cancer.